Prieto Tato L M, La Orden Izquierdo E, Guillén Martín S, Salcedo Lobato E, García Esteban C, García-Bermejo I, Ramos Amador J T
Servicio de Pediatría, Hospital Universitario de Getafe, Getafe, Madrid, España.
An Pediatr (Barc). 2010 May;72(5):347-51. doi: 10.1016/j.anpedi.2009.12.020. Epub 2010 Apr 7.
Visceral leishmaniasis is endemic in Spain. New diagnostic tools and shorter regimens of treatment are been increasingly being used in children.
To analyze the clinical and epidemiological characteristics of cases of visceral leishmaniasis, to evaluate the diagnostic techniques tested and the safety and efficacy of treatments used.
We retrospectively reviewed the medical records of children diagnosed with visceral leishmaniasis between January 1994 and December 2007 in a tertiary public Hospital in the South of Madrid. The diagnosis of visceral leishmaniasis was based on visualization of Leishmania sp. in bone marrow aspirate or culture or positive PCR analysis of the bone marrow aspirate.
Eleven immunocompetent children were identified. Median age was 21 months (range: 4 months - 13 years). Fever was present in all cases, and hepatomegaly and splenomegaly in 10 (91%). Anemia was the most frequent haematological finding (100%). A bone marrow aspirate was obtained in all cases. Leishmania amastigotes were observed in 8 (73%) cases. Leishmania DNA in the bone marrow aspirate was detected in all patients who underwent this procedure. Positive immunofluorescent-antibody test (IFAT) analysis at baseline was observed in 63% of cases tested. The threshold titer for positivity was 1/40. Urinary antigen detection test was positive in 4 out of 6 (67%) children in whom I was performed. Initial treatment consisted of meglumine antimoniate in 3 patients and liposomal amphotericin B (LAB) in 8 (73%) patients. All children had an early clinical response. Only one child treated with LAB relapsed. No severe adverse events were observed with treatment.
Visceral leishmaniasis is still a common disease in our area. Clinical and laboratory findings of visceral leishmaniasis are similar to other Mediterranean area reports. PCR analysis of the bone marrow aspirate was more sensitive than traditional diagnostic techniques. Non-invasive diagnostic techniques may be used as an aid in the diagnosis of visceral leishmaniasis in children. Short course treatment of visceral leishmaniasis with liposomal amphotericin B has been safe and effective.
内脏利什曼病在西班牙呈地方性流行。新的诊断工具和更短疗程的治疗方法越来越多地应用于儿童。
分析内脏利什曼病病例的临床和流行病学特征,评估所测试的诊断技术以及所用治疗方法的安全性和有效性。
我们回顾性分析了1994年1月至2007年12月间在马德里南部一家三级公立医院被诊断为内脏利什曼病的儿童的病历。内脏利什曼病的诊断基于在骨髓抽吸物中发现利什曼原虫、培养阳性或骨髓抽吸物的聚合酶链反应(PCR)分析阳性。
确定了11名免疫功能正常的儿童。中位年龄为21个月(范围:4个月至13岁)。所有病例均有发热,10例(91%)有肝肿大和脾肿大。贫血是最常见的血液学表现(100%)。所有病例均进行了骨髓抽吸。8例(73%)观察到利什曼无鞭毛体。接受该检查的所有患者的骨髓抽吸物中均检测到利什曼原虫DNA。63%接受检测的病例在基线时免疫荧光抗体试验(IFAT)分析呈阳性。阳性阈值滴度为1/40。6名接受该检查的儿童中有4名(67%)尿抗原检测呈阳性。初始治疗3例采用葡甲胺锑酸盐,8例(73%)采用脂质体两性霉素B(LAB)。所有儿童均有早期临床反应。仅1例接受LAB治疗的儿童复发。治疗期间未观察到严重不良事件。
内脏利什曼病在我们地区仍然是一种常见疾病。内脏利什曼病的临床和实验室表现与地中海地区的其他报告相似。骨髓抽吸物的PCR分析比传统诊断技术更敏感。非侵入性诊断技术可辅助诊断儿童内脏利什曼病。脂质体两性霉素B短疗程治疗内脏利什曼病安全有效。